Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fendrix vs. Double-dose Engerix B in HIV-infected HBV Vaccine Non-responders
NCT02434848Phase 3Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2015
- Primary completion
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Started Jul 2015; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02434848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02434848.